1230 related articles for article (PubMed ID: 25548469)
1. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
2. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol.
Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K
J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612
[TBL] [Abstract][Full Text] [Related]
3. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
4. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
5. Dual functional roles of the MyD88 signaling in colorectal cancer development.
Wang L; Yu K; Zhang X; Yu S
Biomed Pharmacother; 2018 Nov; 107():177-184. PubMed ID: 30086464
[TBL] [Abstract][Full Text] [Related]
6. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
7. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.
Tian J; Guo X; Liu XM; Liu L; Weng QF; Dong SJ; Knowlton AA; Yuan WJ; Lin L
Cardiovasc Res; 2013 Jun; 98(3):391-401. PubMed ID: 23447644
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor signaling in primary immune deficiencies.
Maglione PJ; Simchoni N; Cunningham-Rundles C
Ann N Y Acad Sci; 2015 Nov; 1356(1):1-21. PubMed ID: 25930993
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
10. The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
Pisani LP; Estadella D; Ribeiro DA
Anticancer Res; 2017 Oct; 37(10):5389-5394. PubMed ID: 28982847
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production.
Broad A; Kirby JA; Jones DE;
Immunology; 2007 Jan; 120(1):103-11. PubMed ID: 17034424
[TBL] [Abstract][Full Text] [Related]
12. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer.
Moradi-Marjaneh R; Hassanian SM; Fiuji H; Soleimanpour S; Ferns GA; Avan A; Khazaei M
J Cell Physiol; 2018 Aug; 233(8):5613-5622. PubMed ID: 29150944
[TBL] [Abstract][Full Text] [Related]
13. Suppression of TRIF-dependent signaling pathway of toll-like receptors by allyl isothiocyanate in RAW 264.7 macrophages.
Kim SJ; Park HJ; Shin HJ; Shon DH; Kim DH; Youn HS
Int Immunopharmacol; 2012 Aug; 13(4):403-7. PubMed ID: 22668719
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor recognition of bacteria in fish: ligand specificity and signal pathways.
Zhang J; Kong X; Zhou C; Li L; Nie G; Li X
Fish Shellfish Immunol; 2014 Dec; 41(2):380-8. PubMed ID: 25241605
[TBL] [Abstract][Full Text] [Related]
15. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
16. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
18. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
19. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
Hajishengallis G; Sharma A; Russell MW; Genco RJ
Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
[TBL] [Abstract][Full Text] [Related]
20. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
